Unlocking Digital Innovation in Pharma with Nishtha Jain

In this episode of Life Science Success, we dive deep with Dr. John L. LaMattina, former president of Pfizer Global R&D and current biotech industry leader. From groundbreaking drug discoveries to shaping the future of pharmaceuticals, Dr. LaMattina shares his journey from the lab to the boardroom. Gain unique insights into innovation, challenges, and opportunities in life sciences as we explore the ever-evolving world of drug development. Whether you're an industry professional or simply curious about the future of healthcare, this conversation promises to inform and inspire. The episode also ventures into his post-Pfizer endeavors in biotech, where Dr. LaMattina supports innovative ventures in areas like the microbiome and schizophrenia treatment through PureTech Health. He addresses current industry challenges, including drug pricing pressures and the significance of ongoing innovation, emphasizing the critical role of biotechnology and pharma in advancing healthcare. The conversation covers key factors in fostering innovation, the impact of venture capital on drug development, and the pressing need for public understanding and appreciation of the biopharmaceutical industry's contributions.   00:00 Introduction to Life Science Success Podcast 00:39 Sponsor Message: D3 Digital Media Marketing 01:20 Guest Introduction: Dr. John LaMottina 01:48 Dr. LaMottina's Journey from Chemist to Pfizer President 03:57 Challenges and Learnings at Pfizer 05:56 Impact of Torcetrapid and Industry Insights 08:48 Transition to Biotech and PureTech Health 11:50 PureTech Health's Innovative Approach 15:45 Authorship and Industry Advocacy 20:14 Drug Pricing and Industry Challenges 26:37 Future Trends and Innovations in Life Sciences 33:20 Reflections on Career and Contributions 35:08 Fostering Innovation and Overcoming Challenges 37:40 Inspiration, Concerns, and Excitement 41:56 Conclusion and Farewell

Nishtha Jain is a strategic thought leader with over 14 years of experience in global information technology, specializing in digital technology transformations and innovation strategies within the life sciences sector. As the Head of Innovation and Digital Technology at Takeda Pharmaceuticals, she drives digital and data initiatives to enhance global R&D quality and is actively involved in diversity, equity, and inclusion efforts. Nishtha shares her journey from India, discussing the challenges she faced in the competitive field of medicine, leading her to pursue a career in biotechnology. She explores the impact of generative AI in the audit space, emphasizing problem-first approaches and the importance of mental health and diversity in clinical trials. She also reflects on leadership advice, her inspirations, and her passion for travel. This episode offers valuable insights into the intersection of technology and life sciences, urging listeners to consider both the benefits and challenges of innovation.   00:00 Introduction to Life Science Success Podcast 00:35 Sponsor Message from D3 Digital Media Marketing 01:20 Guest Introduction: Nisha Jain 01:47 Nisha's Journey into Life Sciences and Technology 05:08 Achievements and Recognitions 08:22 Career Highlights and Pivotal Moments 13:57 Role at Takeda: Innovation and Digital Technology 17:52 Challenges and Emerging Technologies in Biopharma 26:40 Leadership Advice and Inspirations 31:51 Concerns and Future Challenges 42:23 Excitements and Passions Outside Work 44:12 Conclusion and Farewell

In this episode of the Life Science Success Podcast, my guest is Dr. Zachary S. Brooks, a serial entrepreneur, #1 Best Selling Author, and founder of UGenome AI. Dr. Brooks brings a wealth of experience from his diverse background in technology startups, financial services, and digital authentication. As the founder of UGenome AI, he's at the forefront of developing innovative SaaS tools for genomic medicine. We'll explore his journey from studying bilingual decision-making to becoming a leader in the life sciences field, and discuss how his experiences as an international athlete and multilingual individual have shaped his approach to business and innovation. Dr. Brooks will share insights on the future of personalized medicine, the intersection of genomics and organ transplantation, and the challenges of bringing cutting-edge technology to market. We'll also delve into his work with World Transplant Athletes and his vision for improving healthcare outcomes for organ transplant recipients. This episode promises to be an inspiring and informative conversation about the exciting developments in genomic medicine and the power of entrepreneurship in the life sciences.   00:00 Introduction to Life Science Success Podcast 00:41 Sponsor Message from D3 Digital Media Marketing 01:23 Introducing Dr. Zachary S. Brooks 02:35 Dr. Zachary Brooks' Background and Journey 03:20 The Concept of Anticipated Regret 04:19 Academic and Professional Achievements 07:34 Life Sciences and Personal Health Journey 11:03 Founding Ugenome and Its Mission 13:22 Innovative Tools at UGenome 16:12 The How to Algorithm Series 19:34 World Transplant Athletes and Genomic Medicine 21:51 The Role of Athletics in Entrepreneurship 24:22 Reflecting on Athletic Lessons 27:18 Insights from Previous Startups 31:05 Innovative Projects at UGenome 34:34 Future Aspirations for UGenome 37:51 The Role of Multicultural Experience 41:53 Inspiration and Concerns 45:50 Excitement and Final Thoughts

In this episode of the Life Science Success Podcast, my guest is Dr. Vlad Vitoc, Chairman of the Board, CEO, and President of MAIA Biotechnology. Dr. Vitoc shares his journey from practicing medicine in Romania to leading a cutting-edge biotech company in the United States. We explore MAIA Biotechnology's innovative approach to cancer treatment, focusing on telomere-targeting therapeutics and their lead compound, THIO. Dr. Vitoc offers insights into the challenges of developing new cancer therapies, the future of targeted treatments, and how his international background influences his leadership style.  He also discusses the balance between scientific innovation and commercial viability in the biotech industry. This episode provides a fascinating look into the intersection of medical expertise, business acumen, and scientific innovation in the fight against cancer.   00:00 Introduction to Life Science Success Podcast 00:43 Sponsor Message from D3 Digital Media Marketing 01:24 Introducing Dr. Vlad Vitoc 02:00 Dr. Vitoc's Journey in Oncology 10:08 Innovations in Cancer Treatment 17:20 Challenges and Future Plans 26:35 Global Clinical Development Strategy 28:11 Closing Remarks and Reflections 40:16 Podcast Conclusion and Call to Action

In this episode of the Life Science Success Podcast, my guest is Dr. Russ Lebovitz. Dr. Lebovitz is a seasoned expert in the life sciences, with over 15 years of experience as a senior scientist and research physician. He has served on the faculties of Baylor College of Medicine and The Fox Chase Cancer Center. Transitioning from academia to industry, he has led biotech companies in the diagnostics field, focusing on early detection of neurodegenerative diseases. As the CEO of Amprion, Dr. Lebovitz is pioneering innovative technologies to revolutionize brain health. He collaborates with organizations like the Alzheimer's Drug Discovery Foundation and the Michael J. Fox Foundation to advance research and awareness. Join us as we delve into his remarkable journey and the groundbreaking work he's doing to transform the future of diagnostics. Dr. Lebovitz shares his extensive experience in life sciences, discussing the journey and development of Amprion from its early days to the present. He explains the science behind prion-like particles, misfolded proteins, and how they relate to neurodegenerative diseases such as Alzheimer's and Parkinson's. He also talks about the company's groundbreaking technology, its FDA recognition, and the critical role of collaborations with organizations like the Michael J. Fox Foundation and the Alzheimer's Drug Discovery Foundation. Tune in to learn about the innovations in diagnostics and the impactful strides being made in the field.   00:00 Introduction to Life Science Success Podcast 00:36 Sponsor Message: D3 Digital Media Marketing 01:27 Meet Dr. Russ Lebovitz 01:53 Dr. Lebovitz's Journey in Life Sciences 02:33 Founding Amprion: The Early Days 04:22 Breakthroughs in Neurodegenerative Disease Research 14:27 The Science Behind Amprion's Technology 19:41 Collaborations and FDA Support 24:52 Amprion's Unique Approach and Availability 32:05 Personal Insights and Reflections 37:20 Conclusion and Farewell

In this episode of Life Science Success, my guest is Michelle Briscoe, the Chief Operating Officer and Chief Financial Officer of Talus Bio. We dive into Michelle's extensive 26-year career in leading scientific organizations and her current role at Talus Bio. Michelle shares insights on the company's innovative MARMOT platform for drug discovery, targeting "undruggable" transcription factors. We explore her strategies for creating exceptional workplaces, her experience with M&A, and her co-founding of OUTbio Seattle. Michelle also discusses balancing financial and operational demands in biotech, industry trends, and her leadership philosophy.     In this episode of Life Science Success, host Don engages in an insightful conversation with Michelle Briscoe, the COO and CFO of Talus Bio. Michelle shares her fascinating career journey from growing up in Oregon, falling in love with science, to leading scientific organizations in Seattle. She discusses her transition from bench science to leadership roles, the importance of creating a positive workplace culture, and her experiences with mergers and acquisitions. Michelle also talks about Talus Bio’s mission to drug the undruggable, leveraging AI for rapid drug discovery, and her excitement about building the largest proteomics dataset. Tune in to learn more about Michelle's inspiring story and the innovative work happening at Talus Bio.   00:00 Introduction to Life Science Success Podcast 00:42 Sponsor Message from D3 Digital Media Marketing 01:23 Guest Introduction: Michelle Briscoe, COO and CFO of Talus Bio 01:53 Michelle's Career Journey and Leadership Roles 07:21 Talus Bio: Mission and Innovations 18:42 Creating a Positive Workplace Culture 23:13 Mergers, Acquisitions, and Leadership Insights 27:18 Future of Life Sciences and Personal Reflections 34:34 Conclusion and Farewell

Join us for an insightful conversation with Sanj Singh, CEO of Temple Therapeutics, as we dive into the world of life sciences innovation. With over 18 years of leadership experience in biotech and pharma, Sanj shares his journey from academia to entrepreneurship, and how he's revolutionizing female-centric precision medicine. In this episode, we explore: • Temple Therapeutics' mission and groundbreaking approach to gynecological health • The challenges and opportunities in developing therapies for underserved populations • Sanj's experience with successful biotech startups and high-value asset transactions • The future of precision medicine and early diagnostics • Valuable insights on leadership in the fast-paced world of biotech Discover how Sanj's unique background as a professor of entrepreneurship and his involvement with industry organizations like BIOTECanada are shaping the future of healthcare. Whether you're a biotech enthusiast, aspiring entrepreneur, or simply curious about the latest advancements in medical science, this episode offers something for everyone. Don't miss Sanj's perspective on what inspires, concerns, and excites him about the future of life sciences. Subscribe now and join the conversation on innovation, leadership, and the future of healthcare! 00:00 Introduction to Life Science Success Podcast 00:42 Sponsor Message: D3 Digital Media Marketing 01:24 Guest Introduction: Sanj Singh, CEO of Temple Therapeutics 02:28 Sanj Singh's Background and Journey 05:15 Leadership and Entrepreneurship Insights 08:22 Temple Therapeutics: Mission and Vision 15:00 Challenges in Women's Health Innovation 25:29 Temple Therapeutics' Unique Approach 30:32 Accomplishments and Future Vision 38:02 Personal Reflections and Inspirations 45:59 Conclusion and Farewell

Dive into the cutting-edge world of cancer research and precision medicine with Dr. Wahid Awad, CEO and Founder of Rosetta Omics. In this episode, we explore how spatial multiomics and AI are revolutionizing cancer treatment. Dr. Awad shares his journey from Egypt to founding a biotech startup in France, and discusses the challenges and opportunities in the field of personalized medicine. Learn about the latest advancements in cancer diagnostics, the role of AI in biotechnology, and how global perspectives are shaping the future of healthcare. Whether you're a science enthusiast, healthcare professional, or simply curious about the future of medicine, this episode offers valuable insights into the forefront of cancer research and biotechnology innovation.   In this episode of Life Science Success, host Don interviews Waheed Awad, CEO and founder of Rosetta Omics. Waheed shares his inspiring journey from Egypt to founding his deep-tech biotech startup in France, focusing on precision medicine and cancer research. Listen in to discover Waheed's innovative use of spatial multiomics and AI, his personal motivation stemming from his father's battle with cancer, and his global experiences shaping his entrepreneurial path. Sponsored by D3 Digital Media Marketing, tune in for an engaging conversation about the future of cancer treatment and personalized medicine.     00:00 Introduction to Life Science Success Podcast 00:40 Sponsor Message: D3 Digital Media Marketing 01:22 Guest Introduction: Waheed Awad 03:06 Waheed's Journey from Egypt to France 08:30 Founding Rosetta Omics 10:10 Personal Connection to Cancer Research 15:25 Global Experiences Shaping Biotechnology 24:06 Rosetta Omics: Precision Medicine and AI 31:16 Balancing Roles and Responsibilities 39:50 Challenges and Inspirations 49:09 Conclusion and Final Thoughts  

Join host Don Davis as he sits down with Tarun Mathur CTO at Indegene, a visionary leader in digital transformation for the life sciences industry. With over two decades of experience, Tarun shares his insights on leveraging AI, machine learning, and cutting-edge technologies to solve complex challenges across the pharmaceutical lifecycle. In this episode, you'll discover: • How AI is reshaping drug development, clinical research, and patient care • Strategies for blending domain expertise with technological innovation • The importance of customer-centric approaches in life sciences • Tarun's philosophy on continuous learning and staying ahead of the curve Whether you're a life sciences professional, tech enthusiast, or curious about the future of healthcare, this conversation offers a fascinating glimpse into the intersection of technology and medicine. Tune in to explore how Tarun and his team at Indegene are paving the way for a more efficient, effective, and patient-focused future in life sciences.   Join us for an insightful episode of the Life Science Success Podcast as we dive into the world of AI and digital transformation with Tarun Mathur, a visionary leader in the life sciences industry. Discover Tarun's journey from his early fascination with coding to his role in revolutionizing pharmaceutical life cycles with AI and machine learning at Indigene.   In this episode, we explore the intersection of domain expertise and technology, the challenges and opportunities in the industry, and the exciting potential of emerging technologies like multimodal models and the metaverse. Whether you're in the life sciences field or just interested in the future of AI, this episode is packed with valuable insights and inspiration.     00:00 Introduction to Life Science Success Podcast 00:31 Sponsor Message: D3 Digital Media Marketing 01:23 Guest Introduction: Tarun Mathur 01:58 Tarun's Early Journey in Technology 04:09 First Foray into Healthcare 04:31 Startup Success and Challenges 06:14 Acquisition by Indigene 08:24 Operational Challenges and Remote Work 13:20 AI in Healthcare: Early Beginnings 21:24 AI and Knowledge Engineering 28:53 The Importance of Trust and Accuracy in Pharma Communication 30:56 Balancing Data Privacy and Effective Marketing 32:40 The Future of AI in Digital Marketing 34:54 Challenges Facing Life Sciences in the Next Decade 40:33 Indigene's Approach to Integrating Domain Knowledge and Technology 48:12 Emerging Technologies and Their Impact 50:49 Personal Inspirations and Ethical Concerns 53:52 Conclusion and Final Thoughts

In this episode of Life Science Success, we sit down with Paul Jaminet, Ph.D., founder and CEO of Angiex, Inc., to explore his groundbreaking work in developing Nuclear-Delivered Antibody-Drug Conjugates™ for cancer therapy. Paul shares his unique career journey from astrophysics to biotech, insights into leading innovative projects, and the challenges and triumphs of pushing the boundaries in cancer treatment. Don't miss this inspiring conversation with a visionary leader in the life sciences. 🔗 Learn more about Angiex, Inc.: https://angiex.com/ 📚 Discover Paul's book, "Perfect Health Diet": https://www.amazon.com/Perfect-Health... 🎙️ Subscribe for more insights from top industry leaders!   In this episode of Life Science Success, host Don interviews Paul Jaminet, founder and CEO of Angenex. Paul shares his unique journey from astrophysics to life sciences, detailing his groundbreaking work in developing nuclear delivered antibody drug conjugates targeting angiogenic tumor vasculature. Learn about the challenges, motivations, and scientific discoveries driving Angenex's success.   Sponsored by D3 Digital Media Marketing.     00:00 Introduction to Life Science Success Podcast 00:41 Sponsor Message from D3 Digital Media Marketing 01:23 Interview with Paul Jaminet: Founder and CEO of Angenex 01:45 Paul Jaminet's Journey from Astrophysics to Life Sciences 04:35 The Birth of Angenex and Its Groundbreaking Work 06:34 Challenges and Innovations in Developing Antibody Drug Conjugates 13:07 Phase One Clinical Trials and Progress 25:59 Leadership and Strategic Decisions in Biotech 37:10 Inspiration and Motivation Behind the Work 41:10 Concerns and Future Outlook 46:00 Conclusion and Final Thoughts